• Consensus Rating: Moderate Buy
  • Consensus Price Target: $23.50
  • Forecasted Upside: 36.23%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$17.25
▼ -0.39 (-2.21%)

This chart shows the closing price for NEOG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Neogen Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NEOG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NEOG

Analyst Price Target is $23.50
▲ +36.23% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Neogen in the last 3 months. The average price target is $23.50, with a high forecast of $28.00 and a low forecast of $19.00. The average price target represents a 36.23% upside from the last price of $17.25.

This chart shows the closing price for NEOG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 2 polled investment analysts is to moderate buy stock in Neogen. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/30/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/28/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/25/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/23/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/22/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/18/2024Piper SandlerBoost TargetNeutral ➝ Neutral$17.50 ➝ $19.00Low
10/16/2023Piper SandlerLower TargetNeutral ➝ Neutral$24.00 ➝ $17.50Low
8/14/2023Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$22.00 ➝ $28.00Low
8/7/2023Piper SandlerBoost Target$19.00 ➝ $24.00Low
6/16/2023Wells Fargo & CompanyInitiated CoverageOverweight$22.00Low
4/11/2023Piper SandlerLower Target$20.00 ➝ $19.00Low
1/20/2023Piper SandlerBoost Target$17.00 ➝ $20.00Low
12/14/2022Piper SandlerBoost TargetNeutral$14.00 ➝ $17.00Low
11/22/2022William BlairUpgradeMarket Perform ➝ OutperformLow
10/10/2022Piper SandlerLower TargetNeutral$20.00 ➝ $14.00Low
8/30/2022Piper SandlerLower TargetNeutral$26.00 ➝ $20.00Low
7/11/2022Piper SandlerInitiated CoverageNeutral$25.00N/A
7/23/2020Roth CapitalBoost TargetNeutral$16.75 ➝ $18.75Medium
7/21/2020William BlairReiterated RatingMarket PerformLow
7/14/2020StephensReiterated RatingBuy$22.00High
2/10/2020StephensInitiated CoverageEqual Weight ➝ Overweight$22.00High
12/31/2019Roth CapitalReiterated RatingNeutralMedium
7/24/2019Craig HallumBoost TargetBuy ➝ In-Line$18.00 ➝ $19.50High
5/23/2019GuggenheimInitiated CoverageNeutral ➝ NeutralHigh
3/19/2019Craig HallumUpgradeHold ➝ Buy$15.69Medium
(Data available from 2/21/2019 forward)

News Sentiment Rating

1.06 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 19 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/26/2023
  • 18 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/25/2023
  • 19 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/24/2023
  • 8 very positive mentions
  • 20 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
10/24/2023
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/23/2023
  • 5 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/23/2023
  • 12 very positive mentions
  • 17 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
1/22/2024
  • 10 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/21/2024

Current Sentiment

  • 10 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Neogen logo
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Read More

Today's Range

Now: $17.25
Low: $17.15
High: $17.60

50 Day Range

MA: $18.03
Low: $15.06
High: $20.70

52 Week Range

Now: $17.25
Low: $14.44
High: $24.09

Volume

1,314,295 shs

Average Volume

2,356,565 shs

Market Capitalization

$3.73 billion

P/E Ratio

287.55

Dividend Yield

N/A

Beta

1.12

Frequently Asked Questions

What sell-side analysts currently cover shares of Neogen?

The following Wall Street research analysts have issued research reports on Neogen in the last twelve months: Piper Sandler, StockNews.com, and Wells Fargo & Company.
View the latest analyst ratings for NEOG.

What is the current price target for Neogen?

2 Wall Street analysts have set twelve-month price targets for Neogen in the last year. Their average twelve-month price target is $23.50, suggesting a possible upside of 36.2%. Wells Fargo & Company has the highest price target set, predicting NEOG will reach $28.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $19.00 for Neogen in the next year.
View the latest price targets for NEOG.

What is the current consensus analyst rating for Neogen?

Neogen currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for NEOG.

What other companies compete with Neogen?

How do I contact Neogen's investor relations team?

Neogen's physical mailing address is 620 LESHER PLACE, LANSING MI, 48912. The company's listed phone number is (517) 372-9200 and its investor relations email address is [email protected]. The official website for Neogen is www.neogen.com. Learn More about contacing Neogen investor relations.